Jeri was diagnosed with MS in 1999 and after 8 years of a therapy that was not working for her, she had lost all hope. Encouraged by a new neurologist to consider a clinical trial, she entered the TRANSFORMS study for the first ever pill form of treatment for the disease. Her dramatic story of success compelled Jeri to begin advocating for volunteering.
Research should not be a last resort when all else fails, but should be an option when comparing therapy choices or other interventions. By taking part in a clinical trial patients often experience the benefits of cutting edge treatments long before it’s widely available.